Focus Diagnostics Home
 Home  About Focus Diagnostics  Employment  Contact Us
USA International Certifications Customer Service Account Setup Contact Us Compliance Commitment
Kit Description Photo Guide Schematic FAQ Back to Product List
RIF0600M Epstein-Barr Virus (EBV) VCA IgM Recombinant IFA (RIFA®)
Recombinant immunofluorescent antibody ( RIFA®) test for the detection and semi-quantitation of human serum IgM antibodies to Epstein-Barr viral capsid antigen (VCA). Each kit contains ten 12-well slides prepared with recombinant EBV VCA antigen, IgM pretreatment diluent, IgM RIFA® conjugate, and positive and negative controls.
 
  open pdf document Package Inserts
 

EBV VCA IgM (RIFA®)

Slide 1 Slide 2
IgM Positive Sample IgM Negative Sample
[Picture of EBV rViral slide] [Picture of EBV rViral slide]
Back to Top
 

EBV VCA IgM Recombinant IFA Slide Schematic


Back to Top
Frequently Asked Questions (FAQ)
Q: What does RIFA stand for?
A: It is a trademark for Recombinant Immunofluorescent Assay. It is used in the VCA IgM IFA kit.

Q: Why is the conjugate so dark in this kit?
A: It has a high fluorescein/protein ratio and additional counterstain has been added. 

Q: There doesn’t seem to be much whole cell fluorescence with this antigen why is that?
A: The recombinant seems to give a bulls-eye type fluorescent pattern. The fluorescence around the edge of the cell is more intense with the center having a dimmer fluorescence.

Back to Top
Epstein-Barr Virus (EBV) VCA IgM Recombinant IFA (RIFA<sup>®</sup>)
       
Back to Product List  
       
First FDA Clearance of a 2009 H1N1 Test Given to Focus Diagnostics


FDA Issues Another Emergency Use Authorization for Commercial H1N1 Flu Test to Quest Diagnostics’ Focus Diagnostics


Focus Diagnostics provides the first commercial test for detecting the 2009 H1N1 influenza virus that the FDA has authorized for emergency use.


 
©2010 - Focus Diagnostics - All Rights Reserved - Site Revision ID: WEB.FOCUSDX.C3 - Privacy Policy - Site Map